About this item:

70 Views | 8 Downloads

Author Notes:

Ryan K. Roeder, Ph.D., Professor, Department of Aerospace and Mechanical Engineering, Bioengineering Graduate Program, 148 Multidisciplinary Research Building, University of Notre Dame, Notre Dame, IN 46556, Phone: (574) 631-7003, rroeder@nd.edu

L.L., C.J.G., V.S and R.K.R. designed experiments, analyzed data, and wrote the manuscript. L.L. and C.J.G. were primarily responsible for performing all experiments. T.A.F., C.J.E., L.N., M.L.T., A.T., and G.K. provided assistance in performing experiments and editing the manuscript.

L.L. was supported by a Materials Science and Engineering Program Doctoral Fellowship from the University of Notre Dame. C.J.G was supported by a National Science Foundation (NSF) Graduate Research Fellowship (GE-1650044) and the American Heart Association (AHA) Predoctoral Fellowship (20PRE35080132). C.J.E. was supported by the Martell Family Ph.D. Fellowship at the University of Notre Dame. The authors acknowledge additional support from the Kelly Cares Foundation, National Institutes of Health (R00HL127295), Pediatric Research Alliance, and Emory University Dean’s Imagine, Innovate and Impact (I3) Research Award. The authors acknowledge the Center for Environmental Science and Technology (CEST) for use of ICP-OES and FTIR, the Materials Characterization Facility (MCF) for rheometry, and Dr. Pinar Zorlutuna for providing the myocardial tissue sample, all from the University of Notre Dame.

The authors declare no conflict of interest.

Subjects:

Keywords:

  • Computed Tomography
  • Gelatin Methacryloyl (GelMA) Hydrogel
  • Gold Nanoparticles
  • Photopolymerization
  • Tissue Engineering Scaffold

Methacrylate-Modified Gold Nanoparticles Enable Non-Invasive Monitoring of Photocrosslinked Hydrogel Scaffolds.

Tools:

Journal Title:

Adv Nanobiomed Res

Volume:

Volume 2, Number 7

Publisher:

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Photocrosslinked hydrogels, such as methacrylate-modified gelatin (gelMA) and hyaluronic acid (HAMA), are widely utilized as tissue engineering scaffolds and/or drug delivery vehicles, but lack a suitable means for non-invasive, longitudinal monitoring of surgical placement, biodegradation, and drug release. Therefore, we developed a novel photopolymerizable X-ray contrast agent, methacrylate-modified gold nanoparticles (AuMA NPs), to enable covalent-linking to methacrylate-modified hydrogels (gelMA and HAMA) in one-step during photocrosslinking and non-invasive monitoring by X-ray micro-computed tomography (micro-CT). Hydrogels exhibited a linear increase in X-ray attenuation with increased Au NP concentration to enable quantitative imaging by contrast-enhanced micro-CT. The enzymatic and hydrolytic degradation kinetics of gelMA-Au NP hydrogels were longitudinally monitored by micro-CT for up to one month in vitro, yielding results that were consistent with concurrent measurements by optical spectroscopy and gravimetric analysis. Importantly, AuMA NPs did not disrupt the hydrogel network, rheology, mechanical properties, and hydrolytic stability compared with gelMA alone. GelMA-Au NP hydrogels were thus able to be bioprinted into well-defined three-dimensional architectures supporting endothelial cell viability and growth. Overall, AuMA NPs enabled the preparation of both conventional photopolymerized hydrogels and bioprinted scaffolds with tunable X-ray contrast for noninvasive, longitudinal monitoring of placement, degradation, and NP release by micro-CT.

Copyright information:

© 1999-2024 John Wiley & Sons

Export to EndNote